Suppr超能文献

大鼠肺亚细胞组分对N-亚硝基吡咯烷的体外代谢:非靶组织中的α-羟基化作用

In vitro metabolism of N-nitrosopyrrolidine by rat lung subcellular fractions: alpha-hydroxylation in a non-target tissue.

作者信息

Hecker L I

出版信息

Chem Biol Interact. 1980 Apr;30(1):57-65. doi: 10.1016/0009-2797(80)90114-3.

Abstract

N-Nitrosopyrrolidine is carcinogenic for the liver but not for the lung. Optimal conditions for the metabolism of N-nitrosopyrrolidine (NO-PYR) by rat lung microsomes and post-microsomal supernatant were determined. Neither lung nor liver subcellular fractions were able to form detectable amounts of 3-hydroxyNO-PYR. Liver and lung microsomes could only alpha-hydroxylate NO-PYR, and even though the rates of lung reactions were considerably slower than those of liver, similar products were produced by the action of both lung and liver supernatants on microsomal products. The apparent Km for the lung microsome plus supernatant reaction was approx. 20 mM as compared with 0.36 mM for the liver system. Since both the target and non-target tissue extracts could metabolize NO-PYR by the same pathways, we speculate that alpha-hydroxylation of NO-PYR may be a necessary, but not sufficient cause for its carcinogenic actions.

摘要

N-亚硝基吡咯烷对肝脏具有致癌性,但对肺没有致癌性。确定了大鼠肺微粒体和微粒体后上清液代谢N-亚硝基吡咯烷(NO-PYR)的最佳条件。肺和肝脏的亚细胞部分均无法形成可检测量的3-羟基NO-PYR。肝脏和肺微粒体只能将NO-PYR进行α-羟基化,尽管肺反应的速率比肝脏反应的速率慢得多,但肺和肝脏上清液对微粒体产物的作用产生了相似的产物。肺微粒体加上清液反应的表观Km约为20 mM,而肝脏系统为0.36 mM。由于靶组织和非靶组织提取物都可以通过相同的途径代谢NO-PYR,因此我们推测NO-PYR的α-羟基化可能是其致癌作用的必要但不充分的原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验